Concordant with our previous report, TAGLN was observed to be specifically upregulated in response to TGFβ activation in CRC, whereas TGFβ-signaling inhibitor SB431542 abolished this effect28. The gene discussed is TAGLN; the disease is colorectal carcinoma.